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Human milk contains many bioactive components, including secretory IgA, oligosaccharides, and milk-
associated proteins. We assessed the antiviral effects of several components of milk against mammalian
reoviruses. We found that glucocerebroside (GCB) inhibited the infectivity of reovirus strain type 1 Lang
(T1L), whereas gangliosides GD3 and GM3 and 30-sialyllactose (3SL) inhibited the infectivity of reovirus
strain type 3 Dearing (T3D). Agglutination of erythrocytes mediated by T1L and T3D was inhibited by GD3,
GM3, and bovine lactoferrin. Additionally, a-sialic acid, 3SL, 60-sialyllactose, sialic acid, human lactoferrin,
osteopontin, and a-lactalbumin inhibited hemagglutination mediated by T3D. Using single-gene reassor-
tant viruses, we found that serotype-speciﬁc differences segregate with the gene encoding the viral
attachment protein. Furthermore, GD3, GM3, and 3SL inhibit T3D infectivity by blocking binding to host
cells, whereas GCB inhibits T1L infectivity post-attachment. These results enhance an understanding of
reovirus cell attachment and deﬁne a mechanism for the antimicrobial activity of human milk.
& 2012 Elsevier Inc. All rights reserved.Introduction
Several components of human milk protect against infection
by many pathogens. For example, IgA and IgG contained in human
milk play important roles in mucosal immune protection of
infants and have activity against several viruses including enter-
oviruses, herpesviruses, norovirus, reovirus, respiratory syncytial
virus, rotavirus, and rubella virus (Jiang et al., 2004; Lawrence and
Pane, 2007). Human milk oligosaccharides protect against infec-
tious diarrhea (Morrow et al., 2005), and milk-associated proteins
have antiviral effects against adenovirus (Arnold et al., 2002),
human papillomavirus (Mistry et al., 2007), poliovirus (Marchetti
et al., 1999), and rotavirus (Yolken et al., 1987). However,
mechanisms by which human milk exerts its antiviral activities
have not been fully deﬁned.ll rights reserved.
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l Medical Center, Cincinnati,Reovirus is a member of the Reoviridae and serves as an important
experimental model for studies of virus–receptor interactions and
viral pathogenesis (Danthi et al., 2010). Reovirus attachment occurs
by a multistep adhesion-strengthening process in which viral attach-
ment proteins1 ﬁrst binds to an abundant cell-surface carbohydrate
with low afﬁnity (Barton et al., 2001b), followed by high-afﬁnity
interactions with junctional adhesion molecule-A (JAM-A) (Barton
et al., 2001c, 2001a). Although the carbohydrate bound by serotype
1 reovirus has not been conclusively identiﬁed, serotype 3 reovirus
binds to a-linked sialic acid (SA) (Dermody et al., 1990; Gentsch and
Pacitti, 1985; Paul et al., 1989; Reiter et al., 2011).
Following intramuscular inoculation of newborn mice, proto-
type reovirus strains type 1 Lang (T1L) and type 3 Dearing (T3D)
disseminate to the central nervous system. However, these strains
use different routes of spread and produce distinctly different
diseases. T1L spreads hematogenously (Antar et al., 2009; Boehme
et al., 2009; Tyler et al., 1986) and causes hydrocephalus (Weiner
et al., 1977), whereas T3D spreads by both hematogenous and
neural routes (Boehme et al., 2011) and causes encephalitis
(Weiner et al., 1977). These strain-speciﬁc differences in mode
of spread (Tyler et al., 1986) and cell tropism in the central
nervous system (Dichter and Weiner, 1984; Weiner et al., 1977)
segregate with the S1 gene segment, which encodes viral attach-
ment protein s1 (Lee et al., 1981; Weiner et al., 1980). These
observations suggest that receptor recognition by reovirus
strongly inﬂuences pathogenesis in infected mice.
J.A. Iskarpatyoti et al. / Virology 433 (2012) 489–497490The s1 molecule is a trimer approximately 480 A˚ in length
composed of a ﬁlamentous N-terminal tail and a globular
C-terminal head (Fraser et al., 1990; Furlong et al., 1988). Reovirus
s1 shares striking structural similarities with the adenovirus
attachment protein, ﬁber (Stehle and Dermody, 2003). Each protein
forms a trimer with a tail that partially inserts into the virion at the
icosahedral vertices and a head that projects away from the virion
surface. Boths1 and ﬁber possess an uncommon triple b-spiral fold
in the tail and an eight-stranded b-barrel structure that forms the
head. Discrete regions of reovirus s1 mediate binding to cell-
surface receptors. Sequences in the tail of serotype 3 reovirus bind
to SA (Chappell et al., 1997; 2000; Dermody et al., 1990; Reiter
et al., 2011), while sequences in the head of both serotype 1 and
serotype 3 reovirus bind to JAM-A (Barton et al., 2001c; Schelling
et al., 2007). Serotype 1 reovirus does not have carbohydrate-
binding sequences in an analogous region in the tail (Chappell et al.,
2000). The physiological signiﬁcance of differential glycan utiliza-
tion by the reovirus serotypes is unknown.
To enhance an understanding of the antiviral effects of milk,
we tested components of both human and bovine milk for the
capacity to inhibit the infectivity of reovirus strains T1L and T3D.
We found that several milk constituents display strain-speciﬁc
differences in inhibition of infectivity and erythrocyte binding,
a surrogate for glycan engagement. We determined that these
differences segregate with the s1-encoding S1 gene segment.
Furthermore, we show that gangliosides GD3 and GM3 as well as
30-sialyllactose (3SL) inhibit T3D attachment to cells and provide
evidence for blockade of cell binding as an antiviral mechanism
for certain human milk components.Results
Cytotoxicity of milk components
To deﬁne non-cytotoxic concentrations of milk components, we
monitored the capacity of either HeLa S3 (HeLa) cells or L929 (L)
cells to reduce 3-(4,5-dimethylthiazol-2-yl)- 5-(3-carboxymethox-
yphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). Cells were incu-
bated with milk components, washed, and incubated for 16–18 h
with methyl cellulose medium. Cells were incubated with MTS, and
reduction of MTS (quantiﬁed by absorbance at 490 nm) was used as
a surrogate for cell viability. Concentrations of milk components
that resulted in absorption of less than 50% of the absorption of
mock-treated cells were considered cytotoxic. At the highest con-
centrations tested, n-acetylneuraminic acid (SA) was cytotoxic in
both HeLa cells (Fig. 1A) and L cells (Fig. 1B). The cytotoxic
concentration of SA was comparable in both HeLa cells and L cells.
GD3 was cytotoxic at the highest concentration tested in L cells, and
a-lactalbumin (aLB) was cytotoxic at the highest concentration
tested in HeLa cells. At all concentrations tested, a-sialyllactose
(aSL), 3SL, 6’-sialyllactose (6SL), a-lactose monohydrate (LAC),
bovine lactoferrin (bLF), human lactoferrin (hLF), osteopontin
(OSP), bovine lactoferricin (bLFC), and human lactoferricin (hLFC)
were not cytotoxic in either HeLa cells (Fig. 1A) or L cells (Fig. 1B).
Inhibition of reovirus infectivity by milk components was assessed
using concentrations that were less than the cytotoxic concentra-
tions observed following treatment of HeLa cells or L cells.
Inhibition of reovirus infectivity by milk components
To determine whether milk components inhibit the infectivity
of reovirus strain T1L, components were preincubated with
virus, and either HeLa cells or L cells were inoculated with the
virus–component mixture. Infectivity was determined using an
imager-based immunoﬂuorescence infectivity assay (Iskarpatyotiet al., 2012), and results were compared to a mock-treated virus
control. glucocerebroside (GCB) was the only milk component tested
that inhibited T1L infectivity (Fig. 2). The related gangliosides GD3
and GM3 did not inhibit T1L infection of either HeLa cells (Fig. 2A) or
L cells (Fig. 2B). As a positive control, T1L s1-speciﬁc monoclonal
antibody (mAb) 5C6 potently inhibited T1L (Virgin et al., 1991).
To determine whether milk components inhibit the infectivity
of reovirus strain T3D, components were preincubated with virus,
and HeLa cells or L cells were inoculated with the virus-
component mixture. Infectivity was similarly determined by
immunoﬂuorescence, and results were compared to a mock-
treated virus control. GD3, GM3, and 3SL inhibited T3D infectivity
in both HeLa cells (Fig. 3A) and L cells (Fig. 3B). No signiﬁcant
inhibition was observed following incubation of T3D with 6SL.
aSL, which is a mixture of 3SL and 6SL, resulted in an inter-
mediate level of inhibition of T3D infectivity in both HeLa cells
and L cells, but the effect was not statistically signiﬁcant. The
remaining components had no effect on T3D infectivity (data not
shown). As a positive control, T3D s1-speciﬁc mAb 9BG5 potently
inhibited T3D infectivity (Burstin et al., 1982).
Inhibition of reovirus hemagglutination by milk components
To determine whether milk components are capable of
inhibiting reovirus hemagglutination (HA), HA inhibition (HAI)
assays were performed using component-pretreated T1L and T3D.
GD3, GM3, and bLF inhibited T1L-mediated HA of human erythro-
cytes (Fig. 4A). GD3 and GM3 were the most potent, requiring the
lowest concentrations to inhibit HA. The lowest concentrations that
inhibited T1L HA (HAI concentrations) for bLF were more than 10-
fold greater than the HAI concentrations observed for GD3 and GM3
(Fig. 4C). GCB and the remaining milk components tested did not
inhibit HA by T1L at any concentration tested (Fig. 4A). In contrast,
GD3, GM3, aSL, 3SL, 6SL, SA, bLF, hLF, OSP, and aLB inhibited T3D-
mediated HA of bovine erythrocytes (Fig. 4B). Both GD3 and GM3
potently inhibited T3D HA. The HAI concentration of OSP was
nearly 4-fold greater than the HAI concentrations of GD3 and GM3.
The HAI concentrations of hLF and aLB were each approximately 4-
fold greater than the HAI concentration of OSP. The HAI concentra-
tion of bLF was approximately 25-fold greater than the HAI
concentration of hLF. Finally, SA was the least potent inhibitor of
T3D HA, with an HAI concentration 4-fold greater than that of aSL,
3SL, and 6SL, and more than 140,000-fold greater than the HAI
concentration of GD3 (Fig. 4D). GCB, LAC, bLFC, and hLFC did not
inhibit HA by T3D at any concentration tested (Fig. 4B). As negative
controls, neither phosphate-buffered saline (PBS) (Fig. 4A and B,
PBS) nor milk components (Figs. 4A–C) produced HA. Dimethyl
sulfoxide did not affect reovirus agglutination of red blood cells
(Fig. 4A and B, DMSOþV) and did not produce HA at concentrations
less than a 50:50 (v/v) mixture with PBS (Fig. 4A and B, DMSO). As
positive controls, serial dilutions of virus in PBS were capable of
agglutinating red blood cells until a threshold of 3.9108 particles
for T1L (deﬁned as 1 HA unit for T1L) and 3.1109 particles for T3D
(deﬁned as 1 HA unit for T3D) (Figs. 4A and B, V).
The reovirus S1 gene segment determines strain-speciﬁc differences
in hemagglutination
Since HA is mediated by s1 binding to erythrocyte glycans
(Chappell et al., 1997, 2000; Weiner et al., 1978), we hypothesized
that milk components capable of inhibiting HA do so by blocking
interactions with s1. To test this hypothesis, we assessed milk
component inhibition of HA mediated by reovirus strains rs1HA3
and rs3HA1. Strain rs1HA3 contains nine gene segments from T1L
and the S1 gene segment from T3D, whereas rs3HA1 contains
nine gene segments from T3D and the S1 gene segment from T1L
Fig. 1. Cytotoxicity of milk components. HeLa cells (A) and L cells (B) were treated with the concentrations of milk components shown. Cytotoxicity was assessed using an
MTS assay. The results are expressed as a percentage of mock-treated control. Error bars represent SD.
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by rs1HA3 (Fig. 5B), similar to our ﬁndings with T3D (Fig. 4B).
As anticipated from our studies using T3D, both GD3 and GM3
potently inhibited rs1HA3-mediated HA. The HAI concentrations
of GD3 and GM3 for rs1HA3 were approximately 4-fold and
18-fold greater, respectively, compared to the HAI concentrationsof these components for T3D. The HAI concentrations of aSL, 3SL,
and 6SL for rs1HA3 were comparable to those for T3D (Figs. 4D
and 5D). Only GD3 and GM3 inhibited HA mediated by rs3HA1,
similar to our ﬁndings with T1L (Fig. 4A). The rs3HA1 HAI
concentrations for GD3 and GM3 were comparable to the T1L
HAI concentrations for GD3 and GM3 (Figs. 4C, 5E). As a positive
Fig. 2. Inhibition of T1L infectivity by milk components. Reovirus strain T1L was
preincubated at RT for 1 h with serial dilutions of milk components. HeLa cells (A)
and L cells (B) were adsorbed with component-preincubated T1L at an MOI of
50 PFU/cell at RT for 1 h and incubated at 37 1C for 16–18 h. Cells were ﬁxed and
stained with rabbit anti-reovirus serum, followed by goat anti-rabbit 800 IRDyes
CW-labeled secondary antibody and Draq5TM and Sapphire 700TM cell stains.
Wells with uninfected cells stained with secondary antibody and without cell
stains served as a background control. Plate images were captured using a LI-COR
imager and analyzed with Odyssey v 3.0 software. Relative intensity was
determined by normalizing the intensity of the signal in the 800 nm channel
(anti-reovirus) to the intensity of the signal in the 700 nm channel (cell stains) for
each well. Relative intensity values are expressed as mean percentage of untreated
virus (T1L control) for three independent experiments. Error bars represent SD.
The mAb 5C6 (concentration based on estimated molecular weight) was used as a
positive-inhibitor control. *, Po0.05 by one-way ANOVA.
Fig. 3. Inhibition of T3D infectivity by milk components. Reovirus strain T3D was
preincubated at RT for 1 h with serial dilutions of milk components. HeLa cells (A)
and L cells (B) were adsorbed with component-preincubated T3D at an MOI of
50 PFU/cell at RT for 1 h and incubated at 37 1C for 16–18 h. Cells were ﬁxed and
stained with rabbit anti-reovirus serum, followed by goat anti-rabbit 800 IRDyes
CW-labeled secondary antibody and Draq5TM and Sapphire 700TM cell stains.
Wells with uninfected cells stained with secondary antibody and without cell
stains served as a background control. Plate images were captured using a LI-COR
imager and analyzed with Odyssey v 3.0 software. Relative intensity was
determined by normalizing the intensity of the signal in the 800 nm channel
(anti-reovirus) to the intensity of the signal in the 700 nm channel (cell stains) for
each well. Relative intensity values are expressed as mean percentage of untreated
virus (T3D control) for three independent experiments. Error bars represent SD.
The mAb 9BG5 (concentration based on estimated molecular weight) was used as
a positive-inhibitor control. *, Po0.05 by one-way ANOVA.
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whereas 5C6 inhibited HA mediated by rs3HA1 but not rs1HA3.
Thus, strain-speciﬁc differences in HAI capacity of milk compo-
nents segregate with the reovirus S1 gene segment.
The reovirus S1 gene segment determines strain-speciﬁc differences
in inhibition of infectivity
Since GD3, GM3, aSL, 3SL, and 6SL contain SA, which is a
receptor for serotype 3 reoviruses (Barton et al., 2001b; Gentsch
and Pacitti, 1985; Paul et al., 1989), we hypothesized thatinhibition of reovirus infectivity by these components should be
strain-speciﬁc. To test this hypothesis, GCB, GD3, GM3, aSL, 3SL,
and 6SL were preincubated with either rs1HA3 or rs3HA1, and L
cells were inoculated with each virus-component mixture. Infec-
tivity was determined by immunoﬂuorescence, and results were
compared to a mock-treated virus control. GD3, GM3, and 3SL
inhibited 1HA3 infectivity (Fig. 6A), as these compounds did for
T3D (Fig. 3). Only GCB was capable of inhibiting 3HA1 infectivity
(Fig. 6B), as it did for T1L (Fig. 2). Thus, strain-speciﬁc differences
in inhibition of reovirus infectivity by milk components segregate
with the reovirus S1 gene segment (Fig. 7).
Fig. 4. Inhibition of T1L and T3D HA by milk components. Reovirus strains T1L and T3D (4 HA units) were pretreated with the concentrations of the components shown
and incubated at RT for 1 h. Human erythrocytes were added to component-preincubated T1L (A), and bovine erythrocytes were added to component-preincubated
T3D (B). Cells were treated with PBS alone (PBS) or 1:2 serial dilutions of DMSO, either with virus at 4 HA units (DMSOþV) or without virus (DMSO), as controls. Two-fold
serial dilutions of virus starting at 4 HA units were used as a virus control (V). Milk component without virus was used as a component control (C). Cells were incubated at
4 1C for 3 h and scored for HA. Results are expressed as the lowest concentration of milk component that inhibited HA (HAI concentration) by T1L (C) or T3D (D) for three
independent experiments. Error bars represent SD.
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to cells
Since the inhibition of reovirus infectivity by milk components
segregates with the s1-encoding S1 gene segment, we hypothe-
sized that infection-blocking components would inhibit reovirus
binding to cells. To test this hypothesis, we adsorbed HeLa cells
with either T1L or T3D preincubated with milk components at
4 1C for 1 h to minimize internalization. Binding was quantiﬁed
using ﬂow cytometry, and results were compared to mock-
treated virus. GD3, GM3, and 3SL inhibited T3D binding to HeLa
cells, whereas GCB did not. Interestingly, GCB, which inhibits T1L
infectivity, did not inhibit T1L binding to HeLa cells, suggesting
that GCB inhibits T1L infectivity by altering a s1 function that is
operant following viral attachment.Discussion
In this study, we found that serotype-speciﬁc differences in
inhibition of reovirus infectivity by the milk components GCB,
GD3, GM3, and 3SL are determined by the viral S1 gene segment.
The infectivity of both T1L and rs3HA1 was inhibited by GCB at
similar doses but not by GD3, GM3, or 3SL. In contrast, the
infectivity of both T3D and rs1HA3 was inhibited by GD3, GM3,and 3SL at similar doses but not by GCB. Furthermore, reovirus
HA, which is dependent on s1 binding to glycans on the
erythrocyte surface (Chappell et al., 1997, 2000; Weiner et al.,
1978), was inhibited by milk components. Serotype-speciﬁc
differences in inhibition by aSL, 3SL, and 6SL, which only
inhibited HA mediated by T3D and rs1HA3, were also determined
by the S1 gene segment. Finally, we found that GD3, GM3, and 3SL
inhibited T3D infectivity by blocking virus attachment to cells. In
contrast, GCB, which did not inhibit reovirus HA by either
serotype, did not block T1L cell attachment, suggesting that
GCB blocks a post-attachment step in T1L infection that is
determined by the S1 gene segment. The results are summarized
in Table 1.
The T3D s1 protein binds to a-linked SA (Dermody et al.,
1990; Gentsch and Pacitti, 1985; Paul et al., 1989; Reiter et al.,
2011). All of the milk-associated glycans used in our study that
contain a terminal SA, including GD3, GM3, aSL, 3SL, 6SL, and SA,
inhibited HA mediated by T3D and rs1HA3. However, while a
terminal SA is sufﬁcient to inhibit HA mediated by serotype
3 reoviruses, the potency of the effect is increased by larger
compounds, possibly via interactions of non-SA moieties of the
compound with the s1 protein (Reiter et al., 2011). Interestingly,
only GD3, GM3, and 3SL were capable of inhibiting infection of
HeLa cells and L cells by T3D and rs1HA3. Of these compounds,
GD3 and GM3 were substantially more potent inhibitors of T3D
Fig. 5. The reovirus S1 gene segment determines strain-speciﬁc differences in HAI. (A) Puriﬁed virions of T1L, rs1HA3, T3D, and rs3HA1 were electropheresed in a 4–20%
gradient polyacrylamide gel, followed by ethidium bromide staining. Viral gene segments were visualized using UV irradiation. Gene segments of T1L (red) and T3D (blue)
are indicated. (B, C) Reovirus strains 1HA3 and 3HA1 (4 HA units) were pretreated with the concentrations of the components shown and incubated at RT for 1 h. Bovine
erythrocytes were added to the 1HA3-component mixtures (B), and human erythrocytes were added to the 3HA1-component mixtures (C). Cells were treated with PBS
alone (PBS) and 1:2 serial dilutions of DMSO, either with virus at a concentration of 4 HA units (DMSOþV) or without virus (DMSO), as controls. Two-fold serial dilutions of
virus starting at 4 HA units were used as a virus control (V). Cells were incubated at 4 1C for 3 h and scored for HA. Results are expressed as the lowest concentration of milk
component that inhibited HA (HAI concentration) by 1HA3 (D) or 3HA1 (E) for three independent experiments. Error bars represent SD. ND, HAI was not detected.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
J.A. Iskarpatyoti et al. / Virology 433 (2012) 489–497494infectivity than 3SL, with minimum inhibitory concentrations in
the micromolar range for GD3 and nanomolar range for GM3.
Since the afﬁnity of s1 for SA is in the millimolar range (Reiter
et al., 2011), and the glycan component of GM3 is identical to 3SL,
we think it likely that multivalent interactions as a consequence
of micelles formed by the lipid portions of the gangliosides
explain the much greater inhibitory potency of GD3 and GM3 in
comparison to the free glycans.
The SA-containing milk-associated proteins bLF, hLF, OSP, and
aLB inhibit HA mediated by T3D and rs1HA3. However, these
components did not inhibit infection of either HeLa cells or L cells
by T3D or rs1HA3. These data suggest that although HA mediated
by T3D and rs1HA3 is dependent on SA binding, infection of HeLa
cells and L cells by these viruses is less dependent on binding to
this carbohydrate. These results are consistent with previous
studies indicating that a non-SA-binding serotype 3 reovirus
strain can infect both HeLa cells and L cells (Barton et al.,
2001b; Connolly et al., 2001). It is possible that the glycans
capable of inhibiting infectivity bind to s1 with higher relative
afﬁnity and thus diminish the adhesion strengthening required
for s1 to efﬁciently engage JAM-A. Since HA is completely
dependent on glycan binding, even SA-containing compoundsthat bind s1 with lower relative afﬁnity appear to be capable of
blocking reovirus interactions with erythrocytes.
Although the carbohydrate bound by T1L s1 has not been
conclusively identiﬁed, both GD3 and GM3 inhibited HAmediated
by T1L and rs3HA1, suggesting that T1L s1 engages SA-containing
glycans in some contexts. Concordantly, GCB, which does not
contain SA, was not capable of inhibiting HA mediated by either
serotype 1 reovirus strain. However, the other SA-containing
compounds did not inhibit HA mediated by T1L, suggesting that
T1L s1 binds to terminal SA residues only on some types of
carbohydrates. In contrast, GCB but not GD3 or GM3 inhibited
infection of HeLa cells and L cells by T1L and 3HA1. These results
are surprising because GD3 and GM3 both contain the GCB
moiety. It is possible that engagement of T1L s1 by GD3 or
GM3 is not of sufﬁcient afﬁnity to impede subsequent interac-
tions with JAM-A, analogous to SA-containing compounds that
inhibit T3D HA but not T3D infectivity. We think GCB inhibits T1L
infection by blocking a s1 function independent of glycan
binding, perhaps interfering with JAM-A binding or impeding
conformational changes in s1 during viral disassembly. The
mechanism by which GCB blocks T1L infection is a focus of
ongoing work.
Fig. 6. The reovirus S1 gene segment determines strain-speciﬁc differences in
inhibition of infectivity. Strains rs1HA3 (A) and rs3HA1 (B) were preincubated at
RT for 1 h with serial dilutions of GCB, GD3, GM3, aSL, 3SL, and 6SL. L cells were
adsorbed with component-preincubated virus at an MOI of 50 PFU/cell at RT for
1 h and incubated at 37 1C for 16–18 h. Cells were ﬁxed and stained with rabbit
anti-reovirus serum, followed by goat anti-rabbit 800 IRDyes CW-labeled sec-
ondary antibody and Draq5TM and Sapphire 700TM cell stains. Wells with
uninfected cells and stained with secondary antibody and without cell stains
served as a background control. Plate images were captured using a LI-COR imager
and analyzed with Odyssey v 3.0 software. Relative intensity was determined by
normalizing the intensity of the signal in the 800 nm channel (anti-reovirus) to
the intensity of the signal in the 700 nm channel (cell stains) for each well.
Relative intensity values are expressed as mean percentage of mock-treated virus
(1HA3 control and 3HA1 control) for three independent experiments. Error bars
represent SD. The mAb 9BG5 was used as a positive-inhibitor control for 1HA3,
and the mAb 5C6 was used as a positive-inhibitor control for 3HA1. *,Po0.05 by
one-way ANOVA.
Fig. 7. GM3, GD3, and 3SA inhibit T3D binding to HeLa cells. T1L (A) and T3D (B)
were preincubated at RT for 1 h with GCB (60 mM), GD3 (30 mM), GM3 (30 mM),
3SL (5000 mM), or mAb 5C6 (0.03 mM). HeLa cells were adsorbed with 105 particles
component-preincubated virus/cell at 4 1C for 1 h. Cells were stained with rabbit
anti-reovirus serum, followed by goat anti-rabbit 546 Alexa Fluor secondary
antibody. Cells were ﬁxed in PBS containing 1% paraformaldehyde. Fluorescence
intensity was quantiﬁed using a BD LSRII ﬂow cytometer, and results were
analyzed using FlowJo software. Results are expressed as a normalized mean
ﬂuorescence intensity of three independent experiments. Error bars represent SD.
The mAb 5C6 was used as a positive-inhibitor control for T1L. *,Po0.05 by one-
way ANOVA.
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expressed on cell surfaces. Therefore, these cell-surface molecules
may facilitate viral attachment and entry. Furthermore, it is
possible that interactions with GCB, GD3, and GM3 contribute
to differences in the pathogenesis of serotype 1 and serotype
3 reoviruses in infected animals. Future studies using an in vivo
model could help elucidate the role that these molecules play in
pathogenesis and tropism.
Infectivity of several viruses can be inhibited by milk-associated
glycans, including human immunodeﬁciency virus, inﬂuenza
virus, norovirus, polyomavirus, and rotavirus (Newburg et al.,2005). The mechanisms by which these glycans inhibit viral
replication have not been fully deﬁned. In addition, the antiviral
capacities of many milk components are still being explored.
Results of this study provide evidence that inhibition of virus
attachment to cells is an antiviral mechanism of at least some
human milk glycans. Moreover, the identiﬁcation of milk compo-
nents that inhibit viral replication may aid in selecting supplements
for inclusion in infant formulations of human milk and enhance an
understanding of virus–glycan interactions.Materials and methods
Cells, viruses, and antibodies
HeLa cells were maintained in Dulbecco’s modiﬁed Eagle’s
minimum essential medium (MEM) (Invitrogen, Carlsbad, CA,
USA) supplemented to contain 10% heat-inactivated fetal bovine
serum (FBS), 2 mM l-glutamine, 100 U/mL penicillin, 100 mg/mL
streptomycin (Invitrogen), and 25 ng/mL amphotericin B (Sigma-
Aldrich, St. Louis, MO, USA). Spinner-adapted murine L cells were
grown in suspension culture in Joklik’s modiﬁed Eagle’s MEM
(Lonza, Basel, Switzerland) supplemented to contain 5% FBS, 2 mM
Table 1
Summary of results.
MTS assaya Infectivity assayb HAI assayc
T1L T3D T1L T3D
HeLa cells L Cells HeLa cells L cells HeLa cells L cells Human erythrocytes Bovine erythrocytes
GCB 0.5 0.06 0.06
GD3 0.03 0.03 0.001 0.000035
GM3 0.000003 0.000003 0.0056 0.000038
aSL 0.83
3SL 5 5 0.83
6SL 1.25
SA 25 12.5 5
LAC
bLF 0.01 0.013
hLF 0.00049
OSP 0.00012
aLB 5 0.00061
bLFC
hLFC
a Lowest concentration (mM) toxic to cells.
b Lowest concentration (mM) capable of inhibiting infectivity.
c Lowest concentration (mM) capable of inhibiting HA.
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25 ng/mL amphotericin B.
Laboratory stocks of reovirus strains T1L and T3D were
generated using twice-plaque-puriﬁed isolates of each strain
(Furlong et al., 1988). Strains rs1HA3, which contains nine gene
segments from T1L and the S1 gene segment from T3D, and
rs3HA1, which contains nine gene segments from T3D and the S1
gene segment from T1L, were generated using plasmid-based
reverse genetics (Kobayashi et al., 2007, 2010). Virus particles
were puriﬁed by CsCl gradient centrifugation (Smith et al., 1969).
Viral titers were determined by plaque assay using L cells (Virgin
et al., 1988). The genotypes of T1L, T3D, rs1HA3, and rs3HA1 were
conﬁrmed by electrophoresis of viral particles in 4–20% gradient
sodium dodecyl sulfate polyacrylamide gels. Gels were stained
with ethidium bromide, and gene segments were visualized by
UV-illumination (Wilson et al., 1996).
Reovirus serotype-speciﬁc neutralizing mAbs 5C6 (Virgin et al.,
1991) and 9BG5 (Burstin et al., 1982) were obtained from the
Developmental Studies Hybridoma Bank (Iowa City, Iowa, USA).
Milk components
GD3, GM3, and GCB were purchased from Matreya, LLC
(Pleasant Gap, PA, USA) and suspended in DMSO. aSL, SA, LAC,
hLF, aLB, bLFC, and hLFC were purchased from Sigma-Aldrich. 3SL,
6SL, and bLF were obtained from Pﬁzer Nutrition (Collegeville, PA,
USA). OSP was purchased from R&D Systems (Minneapolis, MN,
USA). Milk components other than GD3, GM3, and GCB were
suspended in Dulbecco’s PBS without calcium or magnesium
(Invitrogen).
Cytotoxicity assay
The maximum non-cytotoxic concentration of milk compo-
nents was established using the CellTiter 96 AQueous assay
(Promega, Madison, WI, USA), which is based on the capacity of
viable cells to metabolically reduce MTS. Conﬂuent monolayers of
HeLa cells or L cells were adsorbed with 2-fold dilutions of each
milk component in PBS at room temperature (RT) for 1 h. Cells
were washed with PBS, overlayed with methyl cellulose medium,
and incubated at 37 1C for 16–18 h. MTS was added to cells
according to the manufacturer’s instructions. Following incuba-
tion at 37 1C for 3 h, absorbance was determined using a BioTekSynergy H1 Hybrid Reader (Winooski, VT, USA) at 490 nm.
Absorbance of treated cells was compared to absorbance of
untreated cells as controls.
Imager-based infectivity inhibition assay
Conﬂuent monolayers of HeLa cells or L cells were adsorbed at
an MOI of 50 PFU/cell with puriﬁed reovirus virions preincubated
with 10-fold dilutions of milk components at RT for 1 h. Infected
cells were incubated at RT for 1 h, overlayed with methyl
cellulose medium, and incubated at 37 1C for 16–18 h. Cells were
ﬁxed and stained with rabbit anti-reovirus serum, followed by
goat anti-rabbit 800 IRDyes CW-labeled secondary antibody and
Draq5TM and Sapphire 700TM cell stains (Iskarpatyoti et al., 2012).
Wells with cells only, stained with secondary antibody and
without cell stains, served as a background control. Plate images
were captured using a LI-COR imager and analyzed with Odyssey
v 3.0 software (LI-COR, Lincoln, NE, USA).
Hemagglutination inhibition assay
HA titers of T1L and rs3HA1 were determined using human
erythrocytes, and those of T3D and rs1HA3 were determined
using bovine erythrocytes (Lerner et al., 1962). Puriﬁed virions (4
HA units) were pretreated with 2-fold dilutions of milk compo-
nents in PBS at RT for 1 h. Bovine erythrocytes (Colorado Serum,
Denver, CO, USA) and type O-positive human erythrocytes (Van-
derbilt University Medical Center Blood Bank, Nashville, TN, USA)
were washed with PBS until the supernatant was clear and
resuspended to 1% (vol/vol) in PBS. Milk component-pretreated
T1L and rs3HA1 were incubated with human erythrocytes and
milk component-pretreated T3D and rs1HA3 were incubated with
bovine erythrocytes at 4 1C for 3 h. The HAI concentration was
determined for each milk component and is deﬁned as the lowest
concentration of component capable of inhibiting virus-induced
HA (Burstin et al., 1982; Virgin et al., 1991).
Flow cytometery
Monolayers of HeLa cells were washed with PBS and detached
from a plate using Cellstripper (Cellgro, Manassas, VA, USA) at
37 1C. Cellstripper was quenched with ﬂuorescence-activated cell
sorter (FACS) buffer (PBS with 2% FBS), and cells were pelleted at
J.A. Iskarpatyoti et al. / Virology 433 (2012) 489–497 4971000g, washed once with PBS, and pelleted again at 1,000g. Cells
were adsorbed at 4 1C for 1 h with 105 particles of reovirus/cell
that had been preincubated with milk components at a concen-
tration sufﬁcient to produce maximum infectivity inhibition.
After adsorption, cells were washed once in FACS buffer, pelleted
at 1000g, and stained in FACS buffer containing rabbit anti-
reovirus serum at 4 1C for 30 min. Cells were washed twice in
FACS buffer, pelleted at 1000g, and stained in FACS buffer
containing goat anti-rabbit 546 Alexa Fluor secondary antibody
at 4 1C for 30 min. Cells were washed twice in FACS buffer and
ﬁxed in PBS containing 1% electron microscopy grade parafor-
maldehyde (Electron Microscopy Sciences, Hatﬁeld, PA, USA).
Virus-bound cells were quantiﬁed using a BD LSRII ﬂow cyto-
meter (BD Biosciences, San Jose, California, USA), and results were
analyzed using FlowJo software.Acknowledgments
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